Preparation of 4-(4'-Hydroxyanilino)-5-anilinophthalimide and 4,5-Bis-(4'-hydroxyanilino)-phthalimide by Microbial Hydroxylation.

Weidner, S; Goeke, K; Trinks, U; Traxler, P; Ucci-Stoll, K; Ghisalba, O

Weidner, S; Goeke, K; Trinks, U; Traxler, P; Ucci-Stoll, K; Ghisalba, O.

Afiliación

Weidner S; b Institute of Enzyme Technology, Heinrich-Heine-University Düsseldorf, Research Center Jülich.
Goeke K; a Novartis Pharma AG, Research, Core Technology Area, Expertise Bioreactions.
Trinks U; a Novartis Pharma AG, Research, Core Technology Area, Expertise Bioreactions.
Traxler P; c Oncology Research, Novartis Pharma Inc.
Ucci-Stoll K; a Novartis Pharma AG, Research, Core Technology Area, Expertise Bioreactions.
Ghisalba O; a Novartis Pharma AG, Research, Core Technology Area, Expertise Bioreactions.

Biosci Biotechnol Biochem ; 63(8): 1497-500, 1999.

Article en En | MEDLINE | ID: mdl-27389513

Palabras clave

4,5-bis-(4'-hydroxyanilino)-phthalimide; 4-(4'-hydroxyanilino)-5-anilinophthalimide; PTK-inhibitors; microbial hydroxylation

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biosci Biotechnol Biochem Asunto de la revista: BIOQUIMICA / BIOTECNOLOGIA Año: 1999 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google